Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

David Kroll to Recombinant Proteins

This is a "connection" page, showing publications David Kroll has written about Recombinant Proteins.

 
Connection Strength
 
 
 
0.076
 
  1. Anchordoquy TJ, Carpenter JF, Kroll DJ. Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration. Arch Biochem Biophys. 1997 Dec 01; 348(1):199-206.
    View in: PubMed
    Score: 0.028
  2. Kroll DJ. Homologous and heterologous protein-protein interactions of human DNA topoisomerase IIalpha. Arch Biochem Biophys. 1997 Sep 15; 345(2):175-84.
    View in: PubMed
    Score: 0.027
  3. Brantley SJ, Oberlies NH, Kroll DJ, Paine MF. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations. J Pharmacol Exp Ther. 2010 Mar; 332(3):1081-7.
    View in: PubMed
    Score: 0.016
  4. Anderson RJ, Sponsel HT, Kroll DJ, Jackson S, Breckon R, Hoeffler JP. Escape from the antiproliferative effect of transforming growth factor-beta 1 in LLC-PK1 renal epithelial cells. Kidney Int. 1994 Mar; 45(3):642-9.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)